Minatx

1 known investors

MiNA Therapeutics develops small activating RNA (RNAa) therapeutics, a class of medicines that boost or restore normal gene function to treat disease. The company advances its own pipeline with an initial focus on genetic medicine and partners with pharmaceutical companies to apply its platform across other therapeutic areas.